Volunteer Intake Remains Open as the Company Prepares to Post Updated Evaluation Results on Its Corporate Website in ...

In a phase 2 study, Ojemda (tovorafenib) led to responses in 43% of adults with melanoma or other solid tumors that carried rare RAF gene changes. Ojemda (tovorafenib) shrank tumors in 10 of 23 adults ...

Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has ...

Melanoma detection is rising, but mortality isn't. Are we catching more dangerous cancers or overlabeling harmless lesions?

It's not a cure for baldness. But it might eliminate crow's feet and laugh lines by telling the tissues in your face how to ...

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

A three-drug combination helped treatment-resistant melanoma respond again to immune-based therapy in mouse experiments. The ...

Doctors in Illinois and Michigan detailed a 46-year-old man with a previous history of skin cancer who bought the peptide Melanotan-II to help with his tanning. Five weeks after he started using the ...

Of course, that’s the natural reaction to seeing these super close-up photos of skin lesions, but taking a good look may just ...

A family-based telehealth intervention improves sun-protective behaviors among children of melanoma survivors but did not ...

In recent weeks, Moderna and Merck reported that their Phase 3 INTerpath-001 trial of personalized cancer vaccine intismeran ...

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans ...